Aktis Oncology, Inc.

Direct answer

Aktis Oncology, Inc. is publicly traded on NASDAQ under the ticker AKTS.

Aktis Oncology, Inc. is a clinical-stage biotechnology firm dedicated to advancing targeted radiopharmaceutical therapies for cancer treatment. Their core innovation lies in a proprietary miniprotein radioconjugate platform, which enables the discovery and development of potent radiopharmaceutical therapies designed to precisely deliver tumor-killing radioisotopes. Among their pipeline candidates is Nectin-4, a...

Can you invest in Aktis Oncology, Inc.?

Yes. Aktis Oncology, Inc. is publicly traded on NASDAQ under the ticker AKTS.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Aktis Oncology, Inc.

Detailed equity research is provided by MarketSnap.